What does MDL-AZ DELTA do?

MDL-AZ DELTA is a specialist medical practice in Roeselare. Private Limited, started on 2 April 2020, 1 establishment.

What is the address of MDL-AZ DELTA?

The registered office of MDL-AZ DELTA is located at Deltalaan 1, 8800 Roeselare.

Is MDL-AZ DELTA still active?

Yes. According to the CBE (31 October 2026) MDL-AZ DELTA is active, legal situation “Normale toestand”, started on 2 April 2020.

Is MDL-AZ DELTA registered on Peppol?

Yes, MDL-AZ DELTA is registered on the Peppol network with ID 0208:0745789151.

What is the enterprise number of MDL-AZ DELTA?

The enterprise number of MDL-AZ DELTA is BE0745789151.

When was MDL-AZ DELTA founded?

MDL-AZ DELTA was founded on 2 April 2020.

Is MDL-AZ DELTA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2020; 5 annual accounts filed, latest fiscal year 2025; 10 directors known from the annual account.

How much profit did MDL-AZ DELTA make in 2025?

MDL-AZ DELTA posted a profit after taxes of € 0 in financial year 2025.

What is the revenue of MDL-AZ DELTA?

As a small company, MDL-AZ DELTA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,889.

MDL-AZ DELTA (Private Limited) - Roeselare - BE0745789151

Q: Who are the directors of MDL-AZ DELTA?

According to the 2025 annual accounts, the directors of MDL-AZ DELTA are: DR. JEF DEWYSPELAERE BV, DR. SOFIE DE MEULDER BV, DOKTER PIETER VANDECANDELAERE BV, DR. DE WULF GASTRO-ENTEROLOGIE BV, DR. CHARLOTTE DE VLOO BV, DR. MAROLLEAU BV, DR. JOCHEN DECAESTECKER BV, DR. DE PAUW FILIP BV.

Dossier MDL-AZ DELTA, printed on 1 November 2026 from databakkes.be/en/0745789151/mdl-az-delta. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

39 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

MDL-AZ DELTA from Roeselare, company number BE0745789151, closed financial year 2025 with a result of € 0 after tax. For that financial year MDL-AZ DELTA recorded a gross margin of € 1,889 and equity of € 5,405. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 5,405

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit

€ 0

Profit after tax over the fiscal year.

Cash in the bank

€ 928,406

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 0.

People and assets in 2025

Wage cost

€ 379

▲ 8% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 556,233

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,964 Gross margin 2022: € 1,964 First fiscal year in the series	€ 2,412 Gross margin 2023: € 2,412 ▲ 23% vs 2022 (€ 1,964) Favourable step	€ 1,721 Gross margin 2024: € 1,721 ▼ 29% vs 2023 (€ 2,412) Unfavourable step	€ 1,889 Gross margin 2025: € 1,889 ▲ 10% vs 2024 (€ 1,721) Favourable step	▲ 10%
Equity	€ 5,405 Equity 2022: € 5,405 First fiscal year in the series	€ 5,405 Equity 2023: € 5,405 Unchanged (€ 5,405) Unchanged	€ 5,405 Equity 2024: € 5,405 Unchanged (€ 5,405) Unchanged	€ 5,405 Equity 2025: € 5,405 Unchanged (€ 5,405) Unchanged
Total debts	€ 2,055,196 Total debts 2022: € 2,055,196 First fiscal year in the series	€ 2,472,920 Total debts 2023: € 2,472,920 ▲ 20% vs 2022 (€ 2,055,196) Unfavourable step	€ 2,821,220 Total debts 2024: € 2,821,220 ▲ 14% vs 2023 (€ 2,472,920) Unfavourable step	€ 3,066,015 Total debts 2025: € 3,066,015 ▲ 9% vs 2024 (€ 2,821,220) Unfavourable step	▲ 9%
Cash	€ 444,855 Cash 2022: € 444,855 First fiscal year in the series	€ 572,671 Cash 2023: € 572,671 ▲ 29% vs 2022 (€ 444,855) Favourable step	€ 907,196 Cash 2024: € 907,196 ▲ 58% vs 2023 (€ 572,671) Favourable step	€ 928,406 Cash 2025: € 928,406 ▲ 2% vs 2024 (€ 907,196) Favourable step	▲ 2%
Balance sheet total	€ 2,060,601 Balance sheet total 2022: € 2,060,601 First fiscal year in the series	€ 2,478,326 Balance sheet total 2023: € 2,478,326 ▲ 20% vs 2022 (€ 2,060,601) Unchanged	€ 2,826,626 Balance sheet total 2024: € 2,826,626 ▲ 14% vs 2023 (€ 2,478,326) Unchanged	€ 3,071,420 Balance sheet total 2025: € 3,071,420 ▲ 9% vs 2024 (€ 2,826,626) Unchanged	▲ 9%

Key figures of MDL-AZ DELTA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MDL-AZ DELTA?

What happened at MDL-AZ DELTA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
Apr 2, 2020 New establishment in Roeselare. KBO
Apr 2, 2020 Start of the company according to the CBE. KBO

In short

From € 0 profit in 2022 to € 0 profit in 2025.

Paid € 743 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

Dr. MAROLLEAU 10%

Dokter Pieter Vandecandelaere 10%

Dr. De Wulf gastro-enterologie 10%

The stake of Dr. MAROLLEAU, Dokter Pieter Vandecandelaere, Dr. De Wulf gastro-enterologie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MDL-AZ DELTA

Behind MDL-AZ DELTA are DR. JEF DEWYSPELAERE BV, DR. SOFIE DE MEULDER BV, DOKTER PIETER VANDECANDELAERE BV, DR. DE WULF GASTRO-ENTEROLOGIE BV, DR. CHARLOTTE DE VLOO BV and DR. MAROLLEAU BV. The shares are held by Dr. MAROLLEAU (10%), Dokter Pieter Vandecandelaere (10%) and Dr. De Wulf gastro-enterologie (10%).